Total Funding
85
78
Total FundingPost-IPO Equity raised
Growth Score
-11 pts
Heat Score
25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
59010
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound.
Michel Nuta: Chief Medical Officer- Martin Deterre: CEO
About the Company
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumors and varicose veins.
Their companyTheraclion a French company created in
2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures, and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limbs.
